LMO4 and cancer: Further delineation of Lmo4 signaling in cisplatin ototoxicity will provide an exciting platform from which to identify new targets for therapeutic intervention, which in turn will enhance the clinical utility of this important anti-cancer drug and improve the quality of life of patients treated with cisplatin.